Global health agencies announced Wednesday that generic versions of a groundbreaking injectable drug to prevent HIV will be made available from 2027 at around $40 a year in more than 100 low and middle-income…
Just because development of a single drug costs not that much does not mean you don’t need to pay for failed drugs too. If many drugs die during trials someone gotta pay for that. Profitability is a better indicator for greed.
Just because development of a single drug costs not that much does not mean you don’t need to pay for failed drugs too. If many drugs die during trials someone gotta pay for that. Profitability is a better indicator for greed.
Gilead’s own words show they aren’t hurting in the least for profits. It’s definitely greed.
You must look at the whole sector as failures sink companies but yes.